Development and implementation of an automated and highly accurate reporting process for NGS-based clonality testing

Sean T Glenn1, Phillip M Galbo1, Jesse D Luce2

  • 1Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Oncotarget
|May 12, 2023
PubMed
Summary

This study developed an automated method using next-generation sequencing (NGS) to accurately detect B and T cell clonality, improving diagnosis of lymphoproliferative disorders.

Related Concept Videos